DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemiaEric Haines(Dana-Farber Cancer Institute), Lyubomir T. Vassilev(Ono Pharmaceutical (United States))Scientific ReportsJune 9, 202110.1038/s41598-021-90500-3Cited by 33SaveCiteExport RISWatch citationsRelated PapersPalbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in<i>KRAS</i>-mutant non-small cell lung cancer|Oncotarget|2018|54